Eli Lilly Aktie

875,40 EUR -4,90 EUR -0,56 %

21:55:51

STU

1.039,00 USD +1,92 USD +0,19 %

nachbörslich22:34:55

BTT

Eli Lilly jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.828,20 Mrd. EUR

KGV46,82Div. Rendite0,56%

WKN858560

ISINUS5324571083

SymbolLLY

Eli Lilly Aktien News

Sortieren:Datum Meistgelesen

28.03.25BenzingaHere's How Much $1000 Invested In Eli Lilly 20 Years Ago Would Be Worth Today

27.03.25MotleyFoolBeyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025

27.03.25EN, Eli LillyLillyDirect platform expands to facilitate access to Alzheimer's disease care

27.03.25PR NewswireLillyDirect platform expands to facilitate access to Alzheimer's disease care

26.03.25BenzingaEli Lilly, Palo Alto Networks Traders Take Note: Direxion's New Leveraged ETFs Are Here

25.03.25ZacksEli Lilly (LLY) Stock Sinks As Market Gains: Here's Why

25.03.25EN, Eli LillyLilly announces details of presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting

25.03.25PR NewswireLilly announces details of presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting

24.03.25BenzingaEli Lilly Shares Rise Over 2% After Key Signal

24.03.25MotleyFoolWhy Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped

24.03.25BenzingaEli Lilly Unusual Options Activity

24.03.25BenzingaChina Courts Apple, Pfizer, Eli Lilly Amid US Pressure, Vice Premier Says Beijing 'Will Continue To Improve The Business Environment'

23.03.25MotleyFoolBetter Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

21.03.25Korea TimesEli Lilly beats Novo Nordisk to launch weight-loss drug Mounjaro in India

20.03.25BenzingaEli Lilly Shares Are Up Today: What's Going On?

20.03.25MotleyFool5 Reasons It's Not Too Late to Buy Eli Lilly Stock

18.03.25ZacksEli Lilly (LLY) Stock Moves -0.27%: What You Should Know

17.03.25BenzingaThis Is What Whales Are Betting On Eli Lilly

17.03.25ZacksEli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know

14.03.25BenzingaVisa, Eli Lilly, Blackstone And A Real Estate Stock On CNBC's 'Final Trades'

12.03.25ZacksEli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know

11.03.25BenzingaUnpacking the Latest Options Trading Trends in Eli Lilly

11.03.25ZacksEli Lilly Rises 7.5% YTD: Time to Buy, Sell or Hold the Stock?

11.03.25BenzingaEli Lilly-Incyte Partnered FDA-Approved Drug Shows Encouraging Efficacy In Adolescent Patients With Patchy Hair Loss

11.03.25MotleyFoolIs Eli Lilly Stock a Buy?

10.03.25MotleyFoolWhy Eli Lilly Stock Flopped Today

08.03.25PR NewswireLilly's baricitinib delivered high rates of hair regrowth for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS study

08.03.25EN, Eli LillyLilly's baricitinib delivered high rates of hair regrowth for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS study

07.03.25BenzingaEli Lilly Direct-To-Consumer Push Shouldn't Worry Distributors: JPMorgan

07.03.25PR NewswireLilly's EBGLYSS® (lebrikizumab-lbkz) single monthly maintenance injection achieved completely clear skin at three years in half of patients with moderate-to-severe atopic dermatitis

07.03.25EN, Eli LillyLilly's EBGLYSS® (lebrikizumab-lbkz) single monthly maintenance injection achieved completely clear skin at three years in half of patients with moderate-to-severe atopic dermatitis

06.03.25ZacksEli Lilly (LLY) Dips More Than Broader Market: What You Should Know

06.03.25BenzingaAlzheimer's Drugs From Eli Lilly And Biogen Still Deemed Too Costly For NHS Funding

04.03.25BenzingaHere's How Much You Would Have Made Owning Eli Lilly Stock In The Last 20 Years

04.03.25MotleyFoolNvidia, Apple, and Eli Lilly: Manufacturing the Future

04.03.25ZacksEli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

02.03.25MotleyFoolWhere Will Eli Lilly Be in 5 Years?

28.02.25PR NewswireLilly to participate in Leerink Partners Global Healthcare Conference

28.02.25EN, Eli LillyLilly to participate in Leerink Partners Global Healthcare Conference

28.02.25PR NewswireLilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) previously treated with a BTK inhi...

Eli Lilly News

Eli Lilly News: auf dieser Seite finden Sie alle Eli Lilly News und Nachrichten zur Eli Lilly Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Eli Lilly News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Eli Lilly News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.